Pharsight

1. List of Solosec drug patents

^new

Patent Number	Company	Patent Title	Patent Expiry
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10335390	LUPIN	Secnidazole for use in the treatment of bacterial vaginosis	Sep, 2035 (12 years from now)
US11000507	LUPIN	Secnidazole for use in the treatment of bacterial vaginosis	Sep, 2035 (12 years from now)
US11020377	LUPIN	Secnidazole for use in the treatment of bacterial vaginosis	Sep, 2035 (12 years from now)
US11000508	LUPIN	Secnidazole for use in the treatment of trichomoniasis	Sep, 2035 (12 years from now)
US10682338	LUPIN	Secnidazole for use in the treatment of bacterial vaginosis	Sep, 2035 (12 years from now)
US10849884	LUPIN	Secnidazole for use in the treatment of bacterial vaginosis	Sep, 2035 (12 years from now)
US10857133	LUPIN	Secnidazole for use in the treatment of bacterial vaginosis	Sep, 2035 (12 years from now)
US11324721	LUPIN	Secnidazole for use in the treatment of trichomoniasis	Sep, 2035 (12 years from now)
US11602522	LUPIN	Secnidazole for use in the treatment of sexually transmitted infection	Sep, 2035 (12 years from now)

Exclusivity	Exclusivity Expiration
New Chemical Entity Exclusivity (NCE)	Sep 15, 2022
New Indication (I)	Jun 30, 2024
New Patient Population (NPP)	Jan 26, 2025
Generating Antibiotic Incentives Now (GAIN)	Sep 15, 2027

NCE-1 date: 2026-09-15

Market Authorisation Date: 15 September, 2017

Treatment: Treatment of bacterial vaginosis in adult women; Treatment of bacterial vaginosis in female patients 12 years of age and older; Treatment of trichomoniasis in patients 12 years of age and older; Treat...

Dosage: GRANULE;ORAL